MRI Systems - Medical Devices Pipeline Assessment, 2018

Published : May-2018

No. of Pages : 329

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 16
2 Introduction 17
2.1 MRI Systems Overview 17
3 Products under Development 18
3.1 MRI Systems - Pipeline Products by Stage of Development 18
3.2 MRI Systems - Pipeline Products by Segment 19
3.3 MRI Systems - Pipeline Products by Territory 20
3.4 MRI Systems - Pipeline Products by Regulatory Path 21
3.5 MRI Systems - Pipeline Products by Estimated Approval Date 22
3.6 MRI Systems - Ongoing Clinical Trials 23
4 MRI Systems - Pipeline Products under Development by Companies 24
4.1 MRI Systems Companies - Pipeline Products by Stage of Development 24
4.2 MRI Systems - Pipeline Products by Stage of Development 27
5 MRI Systems Companies and Product Overview 30
5.1 Advanced MRI Technologies Company Overview 30
5.1.1 Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 ALA Scientific Instruments Inc Company Overview 32
5.2.1 ALA Scientific Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Aspect Imaging Inc Company Overview 33
5.3.1 Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.4 Boston Children's Hospital Company Overview 34
5.4.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Brigham and Women's Hospital Company Overview 35
5.5.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 C4 Imaging, LLC Company Overview 38
5.6.1 C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Canon Medical Systems Corp Company Overview 39
5.7.1 Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 39
5.8 Cincinnati Children's Hospital Medical Center Company Overview 40
5.8.1 Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 Clear Cut Medical Ltd. Company Overview 41
5.9.1 Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
5.10 Diagnosoft Inc Company Overview 45
5.10.1 Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.11 Duke University Company Overview 46
5.11.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 46
5.12 GE Global Research Company Overview 48
5.12.1 GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 48
5.13 GE Healthcare LLC Company Overview 49
5.13.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.14 Georgetown University Company Overview 53
5.14.1 Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Harvard University Company Overview 54
5.15.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 54
5.16 Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview 55
5.16.1 Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.17 Icahn School of Medicine at Mount Sinai Company Overview 57
5.17.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Johns Hopkins University Company Overview 58
5.18.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 KinetiCor Inc Company Overview 60
5.19.1 KinetiCor Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 Koninklijke Philips N.V. Company Overview 61
5.20.1 Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview 61
5.21 Leiden University Company Overview 62
5.21.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Leiden University Medical Center Company Overview 63
5.22.1 Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 63
5.23 Marvel Medtech LLC Company Overview 64
5.23.1 Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 64
5.24 Massachusetts General Hospital Company Overview 66
5.24.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 66
5.25 Max Delbruck Center for Molecular Medicine Company Overview 67
5.25.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 67
5.26 Medical College of Wisconsin Company Overview 68
5.26.1 Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 68
5.27 Mitsubishi Electric Corporation Company Overview 70
5.27.1 Mitsubishi Electric Corporation Pipeline Products & Ongoing Clinical Trials Overview 70
5.28 MRI Robotics LLC Company Overview 71
5.28.1 MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 71
5.29 Neurospin Company Overview 72
5.29.1 Neurospin Pipeline Products & Ongoing Clinical Trials Overview 72
5.30 New York University School of Medicine Company Overview 73
5.30.1 New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 73
5.31 Northwestern University Company Overview 75
5.31.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 75
5.32 Oregon Health & Science University Company Overview 76
5.32.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 76
5.33 Philips Healthcare Company Overview 77
5.33.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 77
5.34 Picofemto LLC Company Overview 80
5.34.1 Picofemto LLC Pipeline Products & Ongoing Clinical Trials Overview 80
5.35 Prism Clinical Imaging, Inc. Company Overview 81
5.35.1 Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.36 Promaxo Inc Company Overview 82
5.36.1 Promaxo Inc Pipeline Products & Ongoing Clinical Trials Overview 82
5.37 Resonance Health Ltd Company Overview 83
5.37.1 Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
5.38 Robin Medical, Inc. Company Overview 85
5.38.1 Robin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.39 Siemens Healthcare GmbH Company Overview 87
5.39.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 87
5.40 Stanford University Company Overview 94
5.40.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 94
5.41 Superconducting Systems Inc Company Overview 97
5.41.1 Superconducting Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 Tel Aviv University Company Overview 98
5.42.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 Time Medical, Inc. Company Overview 99
5.43.1 Time Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.44 Tornado Spectral Systems Company Overview 101
5.44.1 Tornado Spectral Systems Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 University of California Davis Company Overview 102
5.45.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 102
5.46 University of California Los Angeles Company Overview 103
5.46.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 103
5.47 University of Colorado Company Overview 105
5.47.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 105
5.48 University of Illinois Company Overview 107
5.48.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 107
5.49 University of Louisville Company Overview 108
5.49.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 108
5.50 University of Manchester Company Overview 109
5.50.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 109
5.51 University of Michigan Company Overview 110
5.51.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 110
5.52 University of Nottingham Company Overview 111
5.52.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 111
5.53 University of Queensland Company Overview 112
5.53.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 112
5.54 University of Saskatchewan Company Overview 113
5.54.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 113
5.55 University of Strasbourg Company Overview 114
5.55.1 University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 114
5.56 University of Texas Southwestern Medical Center Company Overview 115
5.56.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 115
5.57 University of Virginia Company Overview 116
5.57.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 116
5.58 University of Washington Company Overview 117
5.58.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 117
5.59 Vanderbilt University Company Overview 119
5.59.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 119
5.60 VisionQuest Biomedical LLC Company Overview 121
5.60.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 121
5.61 Weinberg Medical Physics, LLC Company Overview 122
5.61.1 Weinberg Medical Physics, LLC Pipeline Products & Ongoing Clinical Trials Overview 122
5.62 Weizmann Institute of Science Company Overview 123
5.62.1 Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 123
5.63 Wright State University Company Overview 124
5.63.1 Wright State University Pipeline Products & Ongoing Clinical Trials Overview 124
6 MRI Systems- Recent Developments 125
6.1 Mar 26, 2018: Amphion Innovations - Update on Polarean Imaging proposed AIM IPO 125
6.2 Mar 24, 2018: Butterfly Network Announces the World's First Augmented Reality Telemedicine Technology 125
6.3 Mar 22, 2018: iCAD Announces Fourth Quarter And Full-Year 2017 Financial Results 126
6.4 Mar 21, 2018: MR Solutions introduces new gradient coil upgrade service for MRI imaging systems 128
6.5 Mar 20, 2018: SIGNA Premier Licensed by Health Canada 128
6.6 Mar 20, 2018: MR Solutions launches a gradient coil upgrade service for MRI systems 129
6.7 Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 130
6.8 Mar 19, 2018: MRI for prostate cancer diagnosis could change clinical practice 130
6.9 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 131
6.10 Mar 14, 2018: Bruker Appoints Gerald Herman as Interim Chief Financial Officer 133
6.11 Mar 12, 2018: ViewRay Reports Fourth Quarter and Full Year 2017 Financial Results 134
6.12 Mar 07, 2018: Philips again ranks first in medical technology' patents filed at the European Patent Office 135
6.13 Mar 06, 2018: Agfa HealthCare and Hitachi Healthcare Americas Will Cover Full Imaging Portfolio at AAOS 2018 Booth 135
6.14 Mar 06, 2018: DirectMed Parts & Service Receives ISO 13485 Certification for Its Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Parts and Service 136
6.15 Mar 05, 2018: Analogic Reports Financial Results For Second Quarter Ended January 31, 2018 137
6.16 Mar 03, 2018: Charing Cross Hospital in world-leading approach to diagnosing prostate cancer 138
6.17 Mar 02, 2018: Canon Medical Systems Expands Aplio Line Up With New A Series 139
6.18 Mar 01, 2018: Siemens Healthineers expands precision medicine with 1.5T MRI scanner Magnetom Sola and BioMatrix technology 139
6.19 Mar 01, 2018: Samsung Presents its Latest Medical Equipment and Healthcare Solutions at the 2018 European Congress of Radiology 141
6.20 Mar 01, 2018: Government to strengthen regulation of ultrasound, other imaging equipment 142
7 Appendix 326
7.1 Methodology 326
7.2 About GlobalData 329
7.3 Contact Us 329
7.4 Disclaimer 329

1.1 List of Tables
Table 1: MRI Systems - Pipeline Products by Stage of Development 18
Table 2: MRI Systems - Pipeline Products by Segment 19
Table 3: MRI Systems - Pipeline Products by Territory 20
Table 4: MRI Systems - Pipeline Products by Regulatory Path 21
Table 5: MRI Systems - Pipeline Products by Estimated Approval Date 22
Table 6: MRI Systems - Ongoing Clinical Trials 23
Table 7: MRI Systems Companies - Pipeline Products by Stage of Development 24
Table 8: MRI Systems - Pipeline Products by Stage of Development 27
Table 9: Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
Table 10: MRI Cerebral Perfusion Imaging Tool - Product Status 30
Table 11: MRI Cerebral Perfusion Imaging Tool - Product Description 30
Table 12: Multiplexed EPI Imaging Sequence - Product Status 31
Table 13: Multiplexed EPI Imaging Sequence - Product Description 31
Table 14: ALA Scientific Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 15: fMRI Device - Brain Injury - Product Status 32
Table 16: fMRI Device - Brain Injury - Product Description 32
Table 17: Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 18: Stroke-dedicated MRI System - Product Status 33
Table 19: Stroke-dedicated MRI System - Product Description 33
Table 20: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 34
Table 21: Fetal Neuroimaging - Product Status 34
Table 22: Fetal Neuroimaging - Product Description 34
Table 23: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
Table 24: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Status 35
Table 25: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Description 35
Table 26: Magnetic Resonance Elastography - Product Status 36
Table 27: Magnetic Resonance Elastography - Product Description 36
Table 28: MRI - Head And Knee Imaging - Product Status 36
Table 29: MRI - Head And Knee Imaging - Product Description 37
Table 30: C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Table 31: Sirius MRI Marker - Multi-Modality Imaging - Product Status 38
Table 32: Sirius MRI Marker - Multi-Modality Imaging - Product Description 38
Table 33: Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 39
Table 34: Vantage Titan 1.5T - Product Status 39
Table 35: Vantage Titan 1.5T - Product Description 39
Table 36: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 40
Table 37: Pediatric Cardiovascular MRI - Product Status 40
Table 38: Pediatric Cardiovascular MRI - Product Description 40
Table 39: Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 40: ClearSight System - Breast Biopsy - Product Status 41
Table 41: ClearSight System - Breast Biopsy - Product Description 41
Table 42: ClearSight System - Colorectal Cancer - Product Status 42
Table 43: ClearSight System - Colorectal Cancer - Product Description 42
Table 44: ClearSight System - Lung Cancer - Product Status 42
Table 45: ClearSight System - Lung Cancer - Product Description 42
Table 46: ClearSight System - Prostate Cancer - Product Status 43
Table 47: ClearSight System - Prostate Cancer - Product Description 43
Table 48: ClearSight System - Skin Cancer - Product Status 43
Table 49: ClearSight System - Skin Cancer - Product Description 43
Table 50: ClearSight System - Thyroid Cancer - Product Status 44
Table 51: ClearSight System - Thyroid Cancer - Product Description 44
Table 52: Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 53: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Status 45
Table 54: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Description 45
Table 55: Duke University Pipeline Products & Ongoing Clinical Trials Overview 46
Table 56: MRI Scanner - Product Status 46
Table 57: MRI Scanner - Product Description 46
Table 58: Neuro and Body MRI - Product Status 47
Table 59: Neuro and Body MRI - Product Description 47
Table 60: GE Global Research Pipeline Products & Ongoing Clinical Trials Overview 48
Table 61: MRI Brain Scanner - Product Status 48
Table 62: MRI Brain Scanner - Product Description 48
Table 63: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 64: 3.0 T Neonatal MRI scanner - Product Status 49
Table 65: 3.0 T Neonatal MRI scanner - Product Description 49
Table 66: Value MR - Product Status 50
Table 67: Value MR - Product Description 50
Table 68: GE Healthcare LLC - Ongoing Clinical Trials Overview 51
Table 69: 3.0 T Neonatal MRI scanner - Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit 52
Table 70: Georgetown University Pipeline Products & Ongoing Clinical Trials Overview 53
Table 71: Diagnostic Tool - Alzheimer's Disease - Product Status 53
Table 72: Diagnostic Tool - Alzheimer's Disease - Product Description 53
Table 73: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 74: Delta Relaxation Enhanced Magnetic Resonance Device - Product Status 54
Table 75: Delta Relaxation Enhanced Magnetic Resonance Device - Product Description 54
Table 76: Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 77: GlucoCEST - Product Status 55
Table 78: GlucoCEST - Product Description 55
Table 79: MR Imaging - Neurological Diseases - Product Status 56
Table 80: MR Imaging - Neurological Diseases - Product Description 56
Table 81: Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 57
Table 82: 7T MRI - MDD - Product Status 57
Table 83: 7T MRI - MDD - Product Description 57
Table 84: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 58
Table 85: Intravascular Magnetic Resonance Imaging - Product Status 58
Table 86: Intravascular Magnetic Resonance Imaging - Product Description 58
Table 87: MRI-Based Cancer Detection Device - Product Status 59
Table 88: MRI-Based Cancer Detection Device - Product Description 59
Table 89: KinetiCor Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 90: Prospective Motion Correction Device - Product Status 60
Table 91: Prospective Motion Correction Device - Product Description 60
Table 92: Koninklijke Philips N.V. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 93: MR Prodiva 1.5T - Product Status 61
Table 94: MR Prodiva 1.5T - Product Description 61
Table 95: Leiden University Pipeline Products & Ongoing Clinical Trials Overview 62
Table 96: Plasma Antenna - Product Status 62
Table 97: Plasma Antenna - Product Description 62
Table 98: Leiden University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 63
Table 99: Multi-Information MRI - Product Status 63
Table 100: Multi-Information MRI - Product Description 63
Table 101: Marvel Medtech LLC Pipeline Products & Ongoing Clinical Trials Overview 64
Table 102: Solada - 4D - Product Status 64
Table 103: Solada - 4D - Product Description 64
Table 104: Solada - AT - Product Status 65
Table 105: Solada - AT - Product Description 65
Table 106: Solada - R - Product Status 65
Table 107: Solada - R - Product Description 65
Table 108: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 66
Table 109: 3D Magnetic Resonance Spectroscopic Imaging Device - Product Status 66
Table 110: 3D Magnetic Resonance Spectroscopic Imaging Device - Product Description 66
Table 111: Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview 67
Table 112: Fast Spin Echo MRI System - Product Status 67
Table 113: Fast Spin Echo MRI System - Product Description 67
Table 114: Medical College of Wisconsin Pipeline Products & Ongoing Clinical Trials Overview 68
Table 115: MR based Electrical Impedance Tomography - Breast Cancer - Product Status 68
Table 116: MR based Electrical Impedance Tomography - Breast Cancer - Product Description 68
Table 117: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Status 69
Table 118: Multi-parametric MR Imaging - Spinal Disc Degeneration - Product Description 69
Table 119: Mitsubishi Electric Corporation Pipeline Products & Ongoing Clinical Trials Overview 70
Table 120: Full-size MRI Scanner - Product Status 70
Table 121: Full-size MRI Scanner - Product Description 70
Table 122: MRI Robotics LLC Pipeline Products & Ongoing Clinical Trials Overview 71
Table 123: MRI-Guided Breast Biopsy Device - Product Status 71
Table 124: MRI-Guided Breast Biopsy Device - Product Description 71
Table 125: Neurospin Pipeline Products & Ongoing Clinical Trials Overview 72
Table 126: 11.7T MRI System - Product Status 72
Table 127: 11.7T MRI System - Product Description 72
Table 128: New York University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 73
Table 129: Magnetic Resonance Imaging Reconstruction - Product Status 73
Table 130: Magnetic Resonance Imaging Reconstruction - Product Description 73
Table 131: Pediatric MR Imaging - Product Status 74
Table 132: Pediatric MR Imaging - Product Description 74
Table 133: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 75
Table 134: MRI-Based - Oxygen Extraction Fraction - Product Status 75
Table 135: MRI-Based - Oxygen Extraction Fraction - Product Description 75
Table 136: Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 76
Table 137: Contrast-Enhanced Magnetic Resonance Imaging - Product Status 76
Table 138: Contrast-Enhanced Magnetic Resonance Imaging - Product Description 76
Table 139: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 77
Table 140: Ingenia Elition - Product Status 77
Table 141: Ingenia Elition - Product Description 77
Table 142: Magnetic Particle Imaging Scanner - Product Status 78
Table 143: Magnetic Particle Imaging Scanner - Product Description 78
Table 144: Multiva 1.5T MRI System - Product Status 78
Table 145: Multiva 1.5T MRI System - Product Description 79
Table 146: Picofemto LLC Pipeline Products & Ongoing Clinical Trials Overview 80
Table 147: Cliniscan Prostate Support - Product Status 80
Table 148: Cliniscan Prostate Support - Product Description 80
Table 149: Prism Clinical Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 150: Functional Connectivity MRI - Product Status 81
Table 151: Functional Connectivity MRI - Product Description 81
Table 152: Promaxo Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 153: Portable MRI - Product Status 82
Table 154: Portable MRI - Product Description 82
Table 155: Resonance Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
Table 156: MRI Based Test - Liver Fibrosis - Product Status 83
Table 157: MRI Based Test - Liver Fibrosis - Product Description 83
Table 158: MRI-Based Assessment Tool - NASH - Product Status 84
Table 159: MRI-Based Assessment Tool - NASH - Product Description 84
Table 160: Robin Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
Table 161: Head Mounted Augmented Reality System - Product Status 85

1.2 List of Figures
Figure 1: MRI Systems - Pipeline Products by Stage of Development 18
Figure 2: MRI Systems - Pipeline Products by Segment 19
Figure 3: MRI Systems - Pipeline Products by Territory 20
Figure 4: MRI Systems - Pipeline Products by Regulatory Path 21
Figure 5: MRI Systems - Pipeline Products by Estimated Approval Date 22
Figure 6: MRI Systems - Ongoing Clinical Trials 23

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

MRI Systems - Medical Devices Pipeline Assessment, 2018

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027